Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 2, 2012, Pages 587-593

  Arbea, Leire ^a   Martínez Monge, Rafael ^a   Díaz González, Juan A ^a   Moreno, Marta ^a   Rodríguez, Javier ^a   Hernández, Jose Luis ^a   Sola, Jesús Javier ^a   Ramos, Luis Isaac ^a   Subtil, Jose Carlos ^a   Nuñez, Jorge ^a   Chopitea, Ana ^a   Cambeiro, Mauricio ^a   Gaztañaga, Miren ^a   García Foncillas, Jesús ^a   Aristu, Javier ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Capecitabine; Intensity modulated radiation therapy; Locally advanced rectal cancer; Oxaliplatin; Pathological response

Indexed keywords

CAPECITABINE; INTENSITY MODULATED RADIATION THERAPY; OXALIPLATIN; PATHOLOGICAL RESPONSE; RECTAL CANCER;

DISEASE CONTROL; DISEASES; SURGERY; SURVEYS;

PHYSICAL THERAPY;

CAPECITABINE; OXALIPLATIN;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CONTROL; CANCER RISK; CANCER STAGING; CARDIOTOXICITY; CHEMORADIOTHERAPY; CYSTITIS; DERMATITIS; DIARRHEA; DISEASE FREE SURVIVAL; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LEUKOPENIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NAUSEA; OVERALL SURVIVAL; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE; RECTUM CANCER; RECTUM RESECTION; SENSORY NEUROPATHY; SEPSIS; THROMBOCYTOPENIA; URINARY TRACT OBSTRUCTION; VALIDATION STUDY; VOMITING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; DEOXYCYTIDINE; DIARRHEA; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PATIENT COMPLIANCE; PREOPERATIVE CARE; PROCTITIS; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 84861097252     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.06.2008     Document Type: Article

References (33)

1. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
2. R. Sauer, R. Fietkau, and C. Wittekind Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: The German trial CAO/ARO/AIO-94 Colorectal Dis 5 2003 406 415 (Pubitemid 37080645)
3. J.A. Diaz-Gonzalez, F.A. Calvo, and J. Cortes Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation Int J Radiat Oncol Biol Phys 64 2006 1122 1128
4. J.G. Guillem, D.B. Chessin, and A.M. Cohen Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer Ann Surg 241 2005 829 836
5. N.A. Janjan, J. Abbruzzese, and R. Pazdur Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer Radiother Oncol 51 1999 153 160 (Pubitemid 29320309)
6. C. Rodel, P. Martus, and T. Papadoupolos Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 2005 8688 8696 (Pubitemid 46211512)
7. V. Valentini, C. Coco, and A. Picciocchi Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients Int J Radiat Oncol Biol Phys 53 2002 664 674 (Pubitemid 34626505)
8. F.M. Vecchio, V. Valentini, and B.D. Minsky The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer Int J Radiat Oncol Biol Phys 62 2005 752 760 (Pubitemid 40779765)
9. J.F. Bosset, V. Magnin, and P. Maingon Preoperative radiochemotherapy in rectal cancer: Long-term results of a phase II trial Int J Radiat Oncol Biol Phys 46 2000 323 327 (Pubitemid 30067781)
10. J. Garcia-Aguilar, d.A. Hernandez, and P. Sirivongs A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 2003 298 304 (Pubitemid 36331646)
11. M.J. O'Connell, J.A. Martenson, and H.S. Wieand Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery N Engl J Med 331 1994 502 507
12. J.A. Diaz-Gonzalez, L. Arbea, and J. Aristu Rectal cancer treatment: Improving the picture World J Gastroenterol 13 2007 5805 5812 (Pubitemid 350148497)
13. J.P. Machiels, L. Duck, and B. Honhon Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: The RadiOxCape study Ann Oncol 16 2005 1898 1905 (Pubitemid 41724278)
14. C. Rodel, G.G. Grabenbauer, and T. Papadopoulos Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer J Clin Oncol 21 2003 3098 3104 (Pubitemid 46613485)
15. G.A. Hospers, C.J. Punt, and M.E. Tesselaar Preoperative chemoradiotherapy with capecitabine and oxaliplatin in locally advanced rectal cancer. A phase I-II multicenter study of the Dutch Colorectal Cancer Group Ann Surg Oncol 14 2007 2773 2779 (Pubitemid 47460621)
16. D. Koeberle, R. Burkhard, and R. von Moos Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer Br J Cancer 98 2008 1204 1209 (Pubitemid 351481682)
17. C. Rodel, T. Liersch, and R.M. Hermann Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer J Clin Oncol 25 2007 110 117 (Pubitemid 350003058)
18. J.P. Gerard, D. Azria, and S. Gourgou-Bourgade Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2 J Clin Oncol 28 2010 1638 1644
19. G. Luxton, S.L. Hancock, and A.L. Boyer Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate Int J Radiat Oncol Biol Phys 59 2004 267 284 (Pubitemid 38501532)
20. D.E. Heron, K. Gerszten, and R.N. Selvaraj Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: A comparative dosimetric study of dose-volume histograms Gynecol Oncol 91 2003 39 45 (Pubitemid 37188591)
21. L. Arbea, L.I. Ramos, and R. Martinez-Monge Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): Dosimetric comparison and clinical implications Radiat Oncol 5 2010 17
22. J.J. Aristu, L. Arbea, and J. Rodriguez Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer Int J Radiat Oncol Biol Phys 71 2008 748 755
23. F.L. Greene TNM staging for malignancies of the digestive tract: 2003 Changes and beyond Semin Surg Oncol 21 2003 23 29 (Pubitemid 37127471)
24. L. Ruo, S. Tickoo, and D.S. Klimstra Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy Ann Surg 236 2002 75 81 (Pubitemid 34686453)
25. M.M. Oken, R.H. Creech, and D.C. Tormey Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 1982 649 655 (Pubitemid 13149996)
26. L. Arbea, I. Coma-Canella, and R. Martinez-Monge A case of capecitabine-induced coronary microspasm in a patient with rectal cancer World J Gastroenterol 13 2007 2135 2137 (Pubitemid 46795857)
27. C. Fernandez-Martos, C. Pericay, and J. Aparicio Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo Cancer de Recto 3 study J Clin Oncol 28 2010 859 865
28. J. Shia, J.G. Guillem, and H.G. Moore Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome Am J Surg Pathol 28 2004 215 223 (Pubitemid 38124730)
29. H. Bouzourene, F.T. Bosman, and W. Seelentag Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy Cancer 94 2002 1121 1130 (Pubitemid 34150868)
30. O. Dworak, L. Keilholz, and A. Hoffmann Pathological features of rectal cancer after preoperative radiochemotherapy Int J Colorectal Dis 12 1997 19 23 (Pubitemid 27138353)
31. A.M. Mandard, F. Dalibard, and J.C. Mandard Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations Cancer 73 1994 2680 2686 (Pubitemid 24166250)
32. A.T. Shivnani, W. Small, and S.J. Stryker Preoperative chemoradiation for rectal cancer: Results of multimodality management and analysis of prognostic factors Am J Surg 193 2007 389 393
33. C.C. Compton Pathologic prognostic factors in the recurrence of rectal cancer Clin Colorectal Cancer 2 2002 149 160